DOCUMENTATION

Our products are currently undergoing the procedure for obtaining a Registration Certificate from Roszdravnadzor (the Federal Service for Surveillance in Healthcare).

The estimated timeframe for receiving the regulatory documentation is February 2026.
OPTIFARMA LIMITED LIABILITY COMPANY
125212, Moscow, Kronstadtsky Blvd, 6, Building 2, Premises 118/11

Phone: +7 (915) 015-51-69
e-mail: msamogina@optifarma.ru
Navigation